TipRanks
Go Ultimate55% OFF

Natural Health Trends (NHTC) AI Stock Analysis

NHTC

Natural Health Trends

(NASDAQ:NHTC)

Select Model
Rating:37Underperform
Price Target:$0.79â–²(2.06% Upside)
Action:reiterated
Date:10/29/26

The overall score is at the minimum of 37, reflecting a company in severe financial distress. The most significant factor is the unsustainable cash burn and persistent operating losses driven by a structural decline in revenue, as confirmed by both financial statements and segment-level KPI insights. Technicals reinforce this weakness with a strong downtrend, and the high dividend yield is a danger signal rather than a benefit. The earnings call confirms these challenges, with management's cost-cutting efforts failing to offset a 23% drop in sales and a rapidly depleting cash balance.

Positive Factors
Strong gross marginA gross margin above 75% provides meaningful economic room to fund distributor commissions, operating costs, and product development. The improvement tied to manufacturing closer to key markets may support margin durability if the company maintains product pricing and execution.
Negative Factors
Revenue contraction and China disruptionA sharp sales decline directly pressures the distributor network, product volumes, and the company’s ability to absorb fixed operating costs. China-related regulatory uncertainty and paused member activity could remain a durable headwind because Asia has historically been central to operations.

Natural Health Trends Key Performance Indicators (KPIs)

Operating Income by SegmentTracks each segment’s profitability after operating expenses like marketing and administration, highlighting which businesses actually contribute to the company’s bottom line and which require continued investment or restructuring. Identifies where management should allocate capital and where losses may pose a risk to overall earnings.

-$3.00M-$2.00M-$1.00M$0.00$1.00M$2.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

Primary Reporting Unit operating income has steadily eroded since 2021—roughly halving by early‑2026—and is the main driver of the company’s weakening profitability; modest, consistent cuts to corporate overhead have softened the hit but can’t offset the core decline. China is volatile with intermittent recoveries but recurring losses, adding geographic execution risk, while Russia & Kazakhstan remain immaterial. Investors should track whether management can restore demand or margins in the Primary Reporting Unit or deliver deeper structural cost savings to stabilize earnings.

Data provided by:The Fly

Natural Health Trends (NHTC) vs. SPDR S&P 500 ETF (SPY)

-100%-80%-60%-40%-20%0%20%NHTC-80.76%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
$6.40M
Dividend Yield
79.68%
Average Volume (3M)
63.68K
Price to Earnings (P/E)
-5.3
Beta (1Y)
0.68
Revenue Growth
-16.53%
EPS Growth
-1330.39%
Country
US
Employees
119
Sector
Consumer Cyclical
Sector Strength
61
Industry
Specialty Retail

Natural Health Trends Business Overview & Revenue Model

Company Description

Natural Health Trends Corp. (NHTC) operates as an international enterprise specializing in direct sales and e-commerce. It distributes a diverse portfolio of personal care, wellness, and lifestyle products, all marketed under its NHT Global brand. Th...

How the Company Makes Money

NHTC generates revenue primarily from product sales made through its direct-selling (multi-level marketing) distribution model. The company sells health and wellness products (e.g., nutritional supplements and personal care items) to end consumers, w...

Natural Health Trends Earnings Call Summary

Earnings Call Date:Jul 28, 2026(Q2-2026)|% Change Since:-57.69%|Next Earnings Date:Feb 09, 2027
Earnings Call SentimentNegative

The call presented a mix of operational improvements and new product momentum (margin expansion, restructuring savings, improved operating cash flow, product launch, and share repurchase authorization), but these positives were overshadowed by a pronounced revenue decline (-23% year-over-year), a swing to net loss, increased operating loss, significant cash reduction since year-end, and ongoing China-related headwinds and member misconduct that disrupted business. While management is taking disciplined steps to improve efficiency and engagement, near-term financial performance and market challenges weigh heavily on the outlook.

Positive Updates

Gross Margin Improvement
Gross profit margin increased to 75.2% from 73.9% year-over-year (up 1.3 percentage points), driven by transitioning much of product manufacturing from the U.S. to East Asia closer to main markets.

Negative Updates

Significant Revenue Decline
Second quarter net sales were $7.6 million, a 23% decrease from $9.8 million in Q2 2025, primarily due to cautious consumer spending and regulatory uncertainty in China that caused member activity pauses.

Company Guidance

The guidance emphasized financial discipline and execution to drive savings and position the business for recovery: Q2 net sales were $7.6M (down 23% YoY) while gross margin improved to 75.2% from 73.9% and commissions remained 40.9% of revenue; restructuring delivered roughly $300K of savings in the quarter and more than $600K year-to-date with additional savings expected in the second half, SG&A was $3.3M (down $323K YoY), operating loss was $643K (net loss $451K, or $0.05 per diluted share, versus net income $15K prior-year), and the company reported $18.6M of cash and marketable securities at June 30 (down from $28.9M at Dec. 31, 2025) after repurchases and dividends, used $2.2M of operating cash in the first six months (vs $5.2M a year earlier), resumed share repurchases with $15.9M available, and plans customer- and field-focused initiatives (including a 25th‑anniversary event expected to draw more than 1,000 attendees) to support long-term growth.

Natural Health Trends Financial Statement Overview

Summary

Financial performance is critically weak. The income statement shows a persistent and accelerating revenue decline with deepening net losses. Cash flow is the most severe issue, with consistent negative operating and free cash flow indicating an unsustainable cash burn. The only mitigating factor is a conservative balance sheet with very low debt, but this is overshadowed by the deteriorating operations.

Income Statement

28Negative

Balance Sheet

65Positive

Cash Flow

15Very Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue34.12M39.78M42.96M43.92M49.13M60.01M
Gross Profit25.32M29.25M31.79M32.75M36.47M44.99M
EBITDA-1.18M-458.00K751.00K909.00K806.00K1.81M
Net Income-1.43M-882.00K572.00K568.00K313.00K1.08M
Balance Sheet
Total Assets27.26M38.43M55.36M69.09M82.82M98.36M
Cash, Cash Equivalents and Short-Term Investments17.59M28.87M43.94M56.18M69.67M83.84M
Total Debt2.58M3.13M2.64M3.46M4.12M3.17M
Total Liabilities12.26M15.00M22.49M27.49M32.67M38.87M
Stockholders Equity15.00M23.43M32.87M41.60M50.15M59.49M
Cash Flow
Free Cash Flow-3.52M-6.07M-3.42M-4.32M-5.00M791.00K
Operating Cash Flow-3.07M-6.00M-3.37M-4.28M-4.85M1.02M
Investing Cash Flow5.41M8.15M-30.07M-46.00K-143.00K-225.00K
Financing Cash Flow-11.06M-9.21M-9.21M-9.21M-9.14M-9.14M

Natural Health Trends Technical Analysis

Technical Analysis SentimentNegative
Last Price0.77

Price Trends

50DMA1.21Negative
100DMA1.52Negative
200DMA2.26Negative

Market Momentum

MACD-0.11Negative
RSI28.43Positive
STOCH9.70Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NHTC, the sentiment is Negative. The current price of 0.77 is below the 20-day moving average (MA) of 0.90, below the 50-day MA of 1.21, and below the 200-day MA of 2.26, indicating a bearish trend. The MACD of -0.11 indicates Negative momentum. The RSI at 28.43 is Positive, neither overbought nor oversold. The STOCH value of 9.70 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NHTC.

Natural Health Trends Risk Analysis

Natural Health Trends disclosed 40 risk factors in its most recent earnings report. Natural Health Trends reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

1 New Risk
1.Our business in China is subject to compliance with a myriad of applicable laws and regulations, and any actual or alleged violations of those laws or government actions otherwise directed at us could have a material adverse impact on our business and the value of our company.Q2, 2026

Natural Health Trends Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

NHTC against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$18.38B12.79-2.54%3.03%1.52%-15.83%
OCGOCG52Neutral$3.10M0.00-6.73%―203.34%37.54%
MOGUMOGU49Neutral$15.45M49.560.35%―-9.81%―
NHTCNHTC37Underperform$6.40M-5.34-8.13%79.68%-16.53%-1330.39%

* Consumer Cyclical Sector Average

Performance Comparison

-100%0%100%200%NHTCMOGUMIOCGJBDIDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
NHTC and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
NHTCNatural Health Trends Corp0.75-3.18-80.84%
MOGUMogu Inc1.89-0.86-31.27%
MINft Limited Class A0.40-319.60-99.88%
OCGOriental Culture Holding Ltd1.60-1865.65-99.91%
JBDIJBDI Holdings Limited2.36-0.20-7.81%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 29, 2026